SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-24-161987
Filing Date
2024-06-17
Accepted
2024-06-17 06:05:27
Documents
1
Effectiveness Date
2024-06-17

Document Format Files

Seq Description Document Type Size
1 15-12G d826971d1512g.htm 15-12G 10135
  Complete submission text file 0001193125-24-161987.txt   11189
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-39344 | Film No.: 241046871
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)